TRDA
Entrada Therapeutics, Inc. · Healthcare
MPM BIOVENTURES 2018, L.P. sold $462K of Entrada Therapeutics, Inc.
10% owner
Sold$461,546
$7.36Price
62,714Shares
−1%Stake
What TRDA did after the filing
- The stock from Thu, Aug 27 open, $7.02
- −19.2%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Oct 9 close.
Traded Mon, Aug 24. Filed Wed, Aug 26, 9:27 PM ET, after the close. Returns use the Aug 27 open and the Oct 9 close. Not investment advice.